Azenta Announces Earnings Conference Call for Fiscal 2025 Q2
Azenta, Inc. (Nasdaq: AZTA), a leading innovator in life sciences solutions, is all set to announce its financial performance for the second quarter of fiscal 2025. The announcement will cover the period that concluded on March 31, 2025, and will take place on May 7, 2025, prior to the market opening.
Conference Call and Webcast Details
On the same day, Azenta will hold a live conference call and webcast to go over the financial results, starting at 8:30 a.m. Eastern Time. Investors, analysts, and media are invited to join the event through Azenta's official website. After the live session, a replay of the call will be available beginning at 8:30 a.m. ET on the following day, making it easy for stakeholders to stay informed.
About Azenta, Inc.
Azenta, Inc. focuses on accelerating impactful breakthroughs in the life sciences sector. Recognized as a frontrunner in the industry, Azenta offers a comprehensive range of cold-chain sample management solutions along with multiomics services. These offerings play a pivotal role in drug development and clinical research, catering to some of the world's top pharmaceutical and biotech companies, as well as academic and healthcare institutions.
Industry-Leading Brands
Azenta's innovative spirit is reflected through its renowned brands: GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey. This extensive brand portfolio underscores Azenta's commitment to providing reliable services and products to enhance research and treatment options.
Global Presence
Headquartered in Burlington, MA, Azenta operates across North America, Europe, and Asia. This expansive reach ensures that they can offer their state-of-the-art solutions to clients worldwide, facilitating advancements in life sciences and healthcare on a global scale.
Investor Relations at Azenta
Investors looking for more information on additional details or inquiries can connect with the Investor Relations team. Yvonne Perron, Vice President of Financial Planning & Analysis, and Investor Relations, along with her colleague Sherry Dinsmore, are available to assist with queries related to the company’s performance and strategic direction.
Frequently Asked Questions
1. What are the key highlights of Azenta's Q2 earnings announcement?
Azenta’s Q2 earnings announcement will detail the financial performance and achievements of the company for the period ending March 31, 2025, emphasizing growth and strategic advances.
2. When is the conference call for the earnings announcement?
The conference call will be held on May 7, 2025, at 8:30 a.m. Eastern Time, providing insights into the company's financial results.
3. How can participants access the live webcast?
Participants can access the live webcast via Azenta's official website on the day of the event.
4. Who are the key contacts for investors at Azenta?
Yvonne Perron and Sherry Dinsmore are the main contacts for investor inquiries, helping to provide necessary information regarding the company's performance and strategies.
5. What innovations does Azenta offer in life sciences?
Azenta provides a wide range of solutions, including cold-chain management and multiomics services, driving advancements in drug development and clinical research for various healthcare institutions.
